Meta's Twin Headwinds: A $200 Billion Lawsuit and a Cash Flow Squeeze Test Investor Patience

Meta's legal exposure and ballooning AI capex crush free cash flow, sending shares 30% below record highs amid investor skepticism.

The courtroom in Oakland is only one front in Meta's current battle, but it may be the one that ultimately defines how Wall Street prices the stock over the coming months. A coalition of 29 states, spearheaded by California, Colorado, Kentucky and New Jersey, is seeking up to $200 billion in damages — roughly a fifth of the company's current market capitalization of around €1.242 trillion — over allegations that Facebook and Instagram were deliberately engineered to be addictive for minors and that Meta harvested data from users under 13 without parental consent.

That legal exposure now converges with a separate, self-inflicted pressure point: a capital expenditure program that has ballooned to the point where the company's free cash flow has all but evaporated. The shares, trading at €469.55, have shed 17 percent over the past month and sit 30 percent below the September 2025 record high. The stock is also down 16 percent year-to-date, hovering just above its March low and well beneath its long-term moving averages.

The Capex Confession

The sell-off traces back to a series of guidance revisions that began in late October, when Meta lifted its 2025 investment forecast to $72 billion and signaled "significantly higher" spending ahead. By spring, the numbers had grown again: management raised the 2026 capex range to $125–145 billion from a prior $115–135 billion, citing climbing component prices and additional data center costs. Most recently, the company bumped the lower end of its current-year plan by $5 billion, settling on a fresh band of $130–145 billion.

The real shock landed in July. Free cash flow for the second quarter collapsed 91 percent year over year, from $8.55 billion to just $784 million. A disappointing revenue outlook for the current quarter compounded the damage, putting chief executive Mark Zuckerberg under mounting pressure to demonstrate that the multibillion-dollar AI bet will eventually pay off.

Growth Without Profitability

The operational numbers tell a story of a company growing at a furious clip while profitability erodes. Second-quarter 2026 revenue came in at $60.80 billion, up 28 percent from a year earlier and ahead of the $60.22 billion consensus. Earnings per share, however, missed badly: $6.18 against expectations of $7.19.

That divergence — robust top-line growth colliding with margin compression — is precisely what worries skeptics, who point to the absence of clear demand signals and uncertainty about when cash flow will recover. Optimists counter that the AI build-out will eventually translate into better ad targeting and new revenue streams, with some even eyeing the possibility of monetizing excess compute capacity through cloud deals.

BNP Paribas analyst Nick Jones reaffirmed a buy rating on Wednesday with a price target of $855, arguing that surplus data center capacity could be sold via cloud arrangements. The average analyst target sits at $754.14, nearly 38 percent above current levels — a gap that reflects a deeply divided market.

Institutional Caution

The mixed sentiment extends to institutional holders. Union Bancaire Privee increased its position by 4.2 percent in the second quarter and ARS Wealth Advisors added 7.8 percent, while Fidelity cut its stake by 17.77 percent to roughly $54 billion. Reuters reports that nearly half of more than 6,300 institutional investors examined trimmed their exposure to "Magnificent Seven" stocks during the quarter, Meta included.

Technical indicators offer little comfort. The relative strength index sits at 34.8, suggesting oversold conditions, yet volatility around each earnings release has intensified and there are no signs of seller capitulation. A technical bounce, in other words, would not resolve the fundamental questions hanging over the stock.

A Reputational Flashpoint

Adding to the strain, Meta Superintelligence Labs has come under criticism following a reported incident involving the "OpenClaw" framework. For a company staking its entire future narrative on artificial intelligence, any question about the safety of its own systems lands on an exposed nerve.

The trial in Oakland, meanwhile, is expected to generate weeks of headlines regardless of the final outcome. Even a settlement far below the $200 billion figure would leave the company's reputation — and its balance sheet — scarred. The next earnings report, due October 28, will offer the first clear test of whether operational strength can outweigh legal uncertainty. Until then, the market's verdict appears to be: show us the proof.